Skip to main content

Peer Review reports

From: ROS1-ADGRG6 : a case report of a novel ROS1 oncogenic fusion variant in lung adenocarcinoma and the response to crizotinib

Original Submission
30 Nov 2018 Submitted Original manuscript
5 Feb 2019 Author responded Author comments - Shu-guang Xu
Resubmission - Version 2
5 Feb 2019 Submitted Manuscript version 2
3 Apr 2019 Author responded Author comments - Shu-guang Xu
24 Feb 2019 Reviewed Reviewer Report - Tan Bibo
4 Mar 2019 Reviewed Reviewer Report - Shailesh Advani
Resubmission - Version 3
3 Apr 2019 Submitted Manuscript version 3
28 Jun 2019 Author responded Author comments - Shu-guang Xu
11 Apr 2019 Reviewed Reviewer Report - Tan Bibo
29 Apr 2019 Reviewed Reviewer Report - Shailesh Advani
Resubmission - Version 4
28 Jun 2019 Submitted Manuscript version 4
8 Jul 2019 Author responded Author comments - Shu-guang Xu
Resubmission - Version 5
8 Jul 2019 Submitted Manuscript version 5
16 Jul 2019 Author responded Author comments - Shu-guang Xu
Resubmission - Version 6
16 Jul 2019 Submitted Manuscript version 6
Publishing
17 Jul 2019 Editorially accepted
5 Aug 2019 Article published 10.1186/s12885-019-5948-y

You can find further information about peer review here.

Back to article page